HDRN
Hadron Energy, Inc.
$2.66
-8.28%
$88.7M
No data for this timeframe.
Vol
Market Cap$88.7M
Cap SizeMicro Cap
Recent Activity
May 22, 2026
Insider
Katz Avi S sold 87,500 shares
Chairman @ $0.00 ($0.00)
May 22, 2026
Insider
Katz Avi S sold 9,932,246 shares
Chairman @ $0.00 ($0.00)
May 22, 2026
Insider
Katz Avi S sold 29,300 shares
Chairman @ $0.00 ($0.00)
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 22, 2026 | Katz Avi | A | $0.00 |
| May 22, 2026 | Katz Avi | M | $0.00 |
| May 22, 2026 | Katz Avi | J | $0.00 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
1 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 22, 2026 | Katz Avi S | Chairman | A | 87,500 | $0.00 | $0.00 |
| May 22, 2026 | Katz Avi S | Chairman | M | 9,932,246 | $0.00 | $0.00 |
| May 22, 2026 | Katz Avi S | Chairman | J | 29,300 | $0.00 | $0.00 |
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.